Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.

about

Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects

P2860

Q36310511-E4203A63-6A3F-4785-9977-CC3900B8BA39

P2860

Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.

Item

http://www.wikidata.org/entity/Q41668994

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Different protective and repar ...... administration and withdrawal.

@en

type

Item

label

Different protective and repar ...... administration and withdrawal.

@en

prefLabel

Different protective and repar ...... administration and withdrawal.

@en

P1476

Different protective and repar ...... administration and withdrawal.

@en

P2093

Berta Rodríguez-Frutos

http://www.w3.org/2001/XMLSchema#string

Exuperio Díez-Tejedor

http://www.w3.org/2001/XMLSchema#string

Jaime Ramos-Cejudo

http://www.w3.org/2001/XMLSchema#string

Laura Otero-Ortega

http://www.w3.org/2001/XMLSchema#string

María Gutiérrez-Fernández

http://www.w3.org/2001/XMLSchema#string

P2860

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration

Astrocytes: biology and pathology

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.

Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.

Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.

Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

P304

806-814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23532

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Blanca Fuentes

P577

2014-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269726392

http://www.w3.org/2001/XMLSchema#string

P698

25524827

http://www.w3.org/2001/XMLSchema#string

Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.

about

P2860

P2860

Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698